4'-Methyl-α-pyrrolidinobutiophenone
| 4'-Methyl-α-pyrrolidinobutiophenone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
4'-Methyl-α-pyrrolidinobutiophenone (MPBP) is a synthetic stimulant of the cathinone class. It is chemically related to other synthetic cathinones such as mephedrone and MDPV. MPBP is known for its stimulant effects, which are similar to those of other compounds in its class.
Chemical Structure and Properties[edit]
MPBP is a derivative of α-pyrrolidinobutiophenone (α-PBP), with a methyl group attached to the para position of the phenyl ring. The chemical structure of MPBP is characterized by a pyrrolidine ring, which is a common feature in many synthetic cathinones. This structural modification is believed to influence the pharmacological activity of the compound.
Pharmacology[edit]
MPBP acts as a central nervous system stimulant. It is thought to exert its effects primarily by inhibiting the reuptake of neurotransmitters such as dopamine and norepinephrine, leading to increased concentrations of these chemicals in the synaptic cleft and prolonged stimulation of the postsynaptic receptors.
Effects[edit]
The effects of MPBP are similar to those of other stimulant drugs. Users may experience increased alertness, euphoria, and enhanced physical and mental performance. However, these effects are often accompanied by adverse reactions such as anxiety, paranoia, and cardiovascular issues.
Legal Status[edit]
The legal status of MPBP varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may be unregulated, although this is subject to change as new legislation is enacted.
Synthesis[edit]
The synthesis of MPBP involves the reaction of 4-methylpropiophenone with pyrrolidine. This process is similar to the synthesis of other pyrrolidinophenone derivatives and requires careful control of reaction conditions to ensure the desired product is obtained.
Potential Risks and Side Effects[edit]
The use of MPBP carries several risks, including the potential for addiction and adverse health effects. Acute side effects may include increased heart rate, hypertension, and hyperthermia. Chronic use can lead to more severe health issues, including cardiovascular problems and neurological damage.
Related Compounds[edit]
MPBP is part of a larger family of synthetic cathinones, which includes:
- Mephedrone
- Methylenedioxypyrovalerone (MDPV)
- α-Pyrrolidinopentiophenone (α-PVP)
